First Command Bank’s Edwards Lifesciences EW Stock Holding History

First Command Bank’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-960	Closed	-$75K	–	351
2019 Q4	$75K	Hold	960	–	–	0.04%	180
2019 Q3	$70K	Hold	960	–	–	0.04%	185
2019 Q2	$59K	Buy	+960	New	+$58K	0.03%	189
2019 Q1	–	Sell	-1,800	Closed	-$92K	–	424
2018 Q4	$92K	Buy	+1,800	New	+$91.1K	0.05%	158
2017 Q3	–	Sell	-600	Closed	-$24K	–	415
2017 Q2	$24K	Buy	+600	New	+$21.9K	0.02%	276

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

First Command Bank's EW Position: Q1 2020 in Review

First Command Bank sold out of Edwards Lifesciences (EW) in Q1 2020, closing a stake of 960 shares — an estimated $75K sold.

First Command Bank first reported a position in EW in Q2 2017 and held it in 5 quarters. The position peaked at $92K in Q4 2018. 1,019 funds tracked by Wall St. Rank hold EW as of Q1 2020.

First Command Bank reported no remaining Edwards Lifesciences position as of Q1 2020 after selling out during the quarter.
First Command Bank sold 960 Edwards Lifesciences shares in Q1 2020, an estimated $75K.
First Command Bank first reported a position in Edwards Lifesciences in Q2 2017 and held it in 5 quarters.
First Command Bank's Edwards Lifesciences position peaked at $92K in Q4 2018.
1,019 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2020.

Based on First Command Bank's 13F filing for Q1 2020, filed 20 Apr 2020.